Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.
An increasing number of broadly neutralizing antibodies (bnAbs) are considered leads for HIV-1 vaccine development and novel therapeutics. Here, we systematically explored the capacity of bnAbs to neutralize HIV-1 prior to and post-CD4 engagement and to block HIV-1 cell-cell transmission. Cell-cell...
Main Authors: | Lucia Reh, Carsten Magnus, Merle Schanz, Jacqueline Weber, Therese Uhr, Peter Rusert, Alexandra Trkola |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-07-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4497647?pdf=render |
Similar Items
-
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
by: Lucia Reh, et al.
Published: (2018-01-01) -
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
by: Harini Subbaraman, et al.
Published: (2018-07-01) -
Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.
by: Irene A Abela, et al.
Published: (2012-01-01) -
P09-02. Selection pressure of neutralizing antibodies and viral escape continues in late stages of the disease
by: Trkola A, et al.
Published: (2009-10-01) -
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.
by: Oliver F Brandenberg, et al.
Published: (2017-05-01)